ClinVar Miner

Submissions for variant NM_015965.7(NDUFA13):c.170G>A (p.Arg57His)

gnomAD frequency: 0.00001  dbSNP: rs752513525
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV000735414 SCV005086228 likely pathogenic Mitochondrial complex 1 deficiency, nuclear type 28 2024-10-09 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with mitochondrial complex I deficiency, nuclear type 28 (MIM#618249) (PMIDs: 25901006, 32722639). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to histidine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v4) <0.01 for a recessive condition (15 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v4) (26 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated GRIM-19 family domain (DECIPHER). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been observed as homozygous in two siblings with developmental delay, seizures, hypotonia and optic atrophy. The variant was confirmed to be heterozygous in their unaffected parents and an unaffected sibling (PMID: 25901006). (SP) 1001 - This variant has strong functional evidence supporting abnormal protein function. Western blot experiments in fibroblasts from patients homozygous for this variant showed reduced protein levels for NDUFA13 and other CI subunits. Blue native page experiments in these cells also showed a reduction in the abundance of CI and the CI, CIII, CIV supramolecular complex (PMID: 25901006). (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
INSERM U1051, Institut des Neurosciences de Montpellier RCV000239442 SCV000153676 pathogenic Mitochondrial complex I deficiency 2014-05-01 no assertion criteria provided research
OMIM RCV000735414 SCV000611546 pathogenic Mitochondrial complex 1 deficiency, nuclear type 28 2024-07-16 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.